GLP1s are slimming down the shopping basket – Worldpanel by Numerator

Posted 19 November, 2026
Share on LinkedIn

Male shoppers are playing a significant part in the rise of GLP-1 adoption. Image: AdobeStock

GLP-1 weight loss drugs have now displaced more than £1 billion from Britain’s grocery bill, according to new Worldpanel by Numerator research, with pill formats and a growing number of male users pushing household penetration to 8.5%, or 2.6 million adults. For food and drink manufacturers, the data points to a customer base that is expanding fast and shopping differently.

A tipping point in the household

The share of British households with a GLP-1 user has risen from 6.3% in February 2026 to 8.5% in August. That equates to 2.6 million adults in Great Britain using weight loss medication.

At 8.5%, GLP-1 users are now found in as many British households as vegetarians and pescatarians combined. The proportion is also similar to the number of households buying Corona beer (8.4%) or Kellogg’s Rice Krispies (8.6%).

Worldpanel by Numerator has tracked the effect of these drugs on purchasing behaviour since March 2024. This fourth wave of data draws on a total sample of 9,629 households.

Nishita Pattni, senior consultant at Worldpanel by Numerator, said: “GLP-1 users are now found in as many British homes as some of Great Britain’s best-known food and drink brands, and growth is accelerating. In just six months, between February and August 2026, user numbers rose almost as much as they did in the whole of the previous year.”

Pills and men widen the pool

Two shifts stand out. Pills received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) only in June 2026, yet they already account for 11.2% of GLP-1 users, more than one in ten.

Men are also driving growth. They now make up 32% of users, up from 23% in February, a near doubling from 440,000 to 830,000 men.

Pattni said: “For many people, a daily pill is far easier than an injection, and with the surge in male users, we only expect the appeal of these drugs to grow.”

A billion pounds off the shelf

The impact of GLP-1 drugs on grocery spend has now passed £1 billion, up from £780 million in June, with 415 million fewer packs bought. That is equivalent to £389 a year displaced from user households’ shopping baskets.

The research stresses that this is not simply a story of shoppers buying less. Spend and volume are falling at a similar rate overall, but users’ habits are creating winners and losers across categories.

Losers and winners in the aisle

Impulse and indulgence lines are taking the biggest hit. Alcohol spend among users has fallen 15% more than in non-user households, and crisp spend has fallen 15%, which Worldpanel by Numerator describes as one of the clearest signs of reduced impulse consumption as users snack less.

Easy, portion-controlled options are gaining ground. Frozen ready meals have seen a 30% uplift in volume. A more unexpected winner is hot chocolate and malt drinks, up 22% in spend and 16% in volume. The research suggests that while “treating” is in decline among users, small, easy-to-digest, everyday comforts retain their appeal.

Some displaced money is moving elsewhere. GLP-1 users spent £78 million more than expected on health and beauty products in the first year after adoption, and 30% said they had spent more on clothing and footwear.

Time to rethink the range

Chantel Kennaugh, head of public sector and nutrition at Worldpanel by Numerator, said: “Too often, the GLP-1 impact is framed as a story about value or volume decline, but there’s a much more interesting story sitting behind this. From a grocery perspective, this new audience is being more mindful about what and how they eat.”

Several implications follow from the data:

  • This is no longer a niche. Worldpanel by Numerator estimates that GLP-1 usage will surpass 10% of GB households in 2027. Kennaugh said: “This is not a flash-in-the-pan trend, but a seismic change that requires retailers and manufacturers to re-think their strategies.”
  • Impulse-led categories face the sharpest pressure. Crisps and alcohol are already showing the steepest declines among users, so manufacturers reliant on unplanned, indulgent purchases will need to examine how exposed their portfolios are.
  • Portion control is a growth lever. The 30% volume uplift for frozen ready meals suggests that convenient, pre-portioned formats are well placed. Kennaugh pointed to smaller portion sizes as one way to support this audience.
  • Clear labelling matters. Kennaugh said support could be “as simple as producing clear labels that highlight nutrients like high protein”. Such signposting could help users find suitable products without being singled out.
  • Small comforts still sell. The rise of hot chocolate and malt drinks shows that users have not abandoned enjoyment, and that smaller, gentler treats may find a home in their baskets.
  • The audience is broadening. With pills lowering the barrier to use and men making up almost a third of users, manufacturers should avoid assuming a single, narrow GLP-1 shopper.

Kennaugh’s guidance for retailers is to support these shoppers “without isolating them”. The same principle applies to the brands that supply them.

 

Read more